Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC Enbezotinib (TPX-0046) | 2359649-81-1 | 99.5% | 424.43 g/mol | C21H21FN6O3 | 5 MG
Supplier: Medchemexpress LLC HY1455655MG
Enbezotinib is a small-molecule RET kinase inhibitor for preclinical cancer research. It inhibits RET autophosphorylation, exhibits potent in vitro activity against RET-driven cells, and has demonstrated tumor size reduction in animal models. Supplied as a high-purity solid with solution formats available for laboratory use.
- Inhibits RET autophosphorylation.
- Potent in vitro activity against RET-driven cells.
- Demonstrated tumor growth reduction in animal models.
- High-purity solid and solution formats available.
- Intended for research use only.
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?